+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Colchicine (CAS 64-86-8) Global Market Research Report 2024 - Product Thumbnail Image

Colchicine (CAS 64-86-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bivalirudin (CAS 128270-60-0) Global Market Research Report 2024 - Product Thumbnail Image

Bivalirudin (CAS 128270-60-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bisoprolol (CAS 66722-44-9) Global Market Research Report 2024 - Product Thumbnail Image

Bisoprolol (CAS 66722-44-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Candesartan (CAS 139481-59-7) Global Market Research Report 2024 - Product Thumbnail Image

Candesartan (CAS 139481-59-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bepridil (CAS 49571-04-2) Global Market Research Report 2024 - Product Thumbnail Image

Bepridil (CAS 49571-04-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Captopril (CAS 62571-86-2) Global Market Research Report 2024 - Product Thumbnail Image

Captopril (CAS 62571-86-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Acebutolol (CAS 37517-30-9) Global Market Research Report 2024 - Product Thumbnail Image

Acebutolol (CAS 37517-30-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more